Bio
Prof. Giuseppe Remuzzi was born in Bergamo, Italy in 1949. Upon completion of his medical training at the University of Pavia in 1974, he received specialty training in Hematology…
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
WCN26-5461 ORAL IPTACOPAN THERAPY IN C3 GLOMERULOPATHY SHOWS CONSISTENT STABILIZATION OF eGFR SLOPE ACROSS PATIENT SUBGROUPS
David J. Kavanagh, Andrew S. Bomback, C. Nester, Robert M. Smith, Liz Lightstone, Marina Vivarelli, Sophie Chauvet, Ming‐Hui Zhao, Aiko PJ de Vries, Jean Grisouard, David Lawrence, Anna Aldea, Olivier Somenzi, Giuseppe Remuzzi (2026). WCN26-5461 ORAL IPTACOPAN THERAPY IN C3 GLOMERULOPATHY SHOWS CONSISTENT STABILIZATION OF eGFR SLOPE ACROSS PATIENT SUBGROUPS. , 11(4), DOI: https://doi.org/10.1016/j.ekir.2026.105746.
Article4 days agoThe burden of disease in Italy, 1990-2023: a subnational analysis from the Global Burden of Disease Study 2023.
Giulia Zamagni, Benedetta Armocida, Giulio Castelpietra, Sara Conti, Paolo Angelo Cortesi, Pietro Ferrara, C Fornari, Silvano Gallus, Matilde Leonardi, Roberto Passera, Norberto Perico, Alberto Raggi, Giuseppe Remuzzi, Luca Ronfani, Lorenzo Monasta (2026). The burden of disease in Italy, 1990-2023: a subnational analysis from the Global Burden of Disease Study 2023.. , 50(1), DOI: https://doi.org/10.19191/ep26.1.a991.020.
Article4 days agoWCN26-4069 EFFICACY AND SAFETY OF IPTACOPAN IN PARTICIPANTS WITH C3 GLOMERULOPATHY: C3G EXTENSION TRIAL INTERIM RESULTS FROM THE PHASE 3 APPEAR-C3G PARTICIPANTS
C. Nester, Richard J.H. Smith, David Kavanagh, Marina Vivarelli, Giuseppe Remuzzi, Ming-hui Zhao, Edwin K.S. Wong, Y. Wang, Rubeen Israni, Hari Kalluri, Ipsita Krishnan, Jean Grisouard, Andrew S. Bomback (2026). WCN26-4069 EFFICACY AND SAFETY OF IPTACOPAN IN PARTICIPANTS WITH C3 GLOMERULOPATHY: C3G EXTENSION TRIAL INTERIM RESULTS FROM THE PHASE 3 APPEAR-C3G PARTICIPANTS. , 11(4), DOI: https://doi.org/10.1016/j.ekir.2026.106215.
Article4 days agoWCN26-3819 UPDATE TO THE LONG-TERM EFFICACY AND SAFETY OF IPTACOPAN IN C3 GLOMERULOPATHY: 39-MONTH PHASE 2 EXTENSION STUDY DATA
C. Nester, Ute Eisenberger, Alexandre Karras, Moglie Le Quintrec, Liz Lightstone, Manuel Praga, Giuseppe Remuzzi, María Soler, Junhao Liu, Rubeen Israni, Jean Grisouard, Ipsita Krishnan, Edwin Wong (2026). WCN26-3819 UPDATE TO THE LONG-TERM EFFICACY AND SAFETY OF IPTACOPAN IN C3 GLOMERULOPATHY: 39-MONTH PHASE 2 EXTENSION STUDY DATA. , 11(4), DOI: https://doi.org/10.1016/j.ekir.2026.106208.
Article4 days agoComments on “Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy in Nigeria (PIPSICKLE): a randomised controlled trial”
Sistiana Aiello, Ariela Benigni, Giuseppe Remuzzi (2026). Comments on “Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy in Nigeria (PIPSICKLE): a randomised controlled trial”. , 5(1), DOI: https://doi.org/10.4081/btvb.2026.463.
Article4 days ago
.webp)